Prevention and Treatment
Every year, hundreds of thousands of patients develop a surgical site infection, and an estimated 40-60% of these are considered preventable. The US Center for Disease Control and Prevention and numerous clinical studies outline guidelines for the prevention or reduced risk of surgical site infections. These include:
- Practicing proper surgical team hand preparation
- Ventilating and sterilizing the operating room
- Using appropriate surgical attire and drapes
- Consulting with patients before surgery to make sure they receive clear and consistent information about surgical site infections, prevention methods, and treatment options
- Preparing skin at surgical sites before incisions with antiseptic preparation
- Avoiding shaving patients where possible
- Actively warming patients for two hours prior to anesthesia to preempt heat loss during surgery
- Providing supplemental perioperative oxygen therapy
- Using prophylactic antibiotics and antimicrobial agents appropriately
Are There Other Ways to Prevent Surgical Site Infections?
For patients at high risk of surgical site infection, additional precautions may be necessary; including the use of a medical device that delivers high doses of antibiotics directly at the site of infection risk.
This device, Collatamp G, provides additional protection for high risk patients. It's been shown in clinical studies to reduce surgical site infections by more than 50%.3 Collatamp G can be placed in a surgical wound during surgery. It uses a novel, patented formula containing a collagen matrix impregnated with the broad spectrum antibiotic gentamicin. The collagen impact is saturated with gentamicin, a powerful broad-spectrum antibiotic that delivers high concentration of gentamicin at the target site, while avoiding the risk of systemic toxicity and associated side effects.
By delivering a high localized dose of gentamicin directly to the surgical site, Collatamp G kills bacteria that may be antibiotic-resistant at lower doses.2
Collatamp G is a strong, effective adjunct to the lower dose prophylactic antibiotic protocols that are already used at your hospital. Collatamp G has been used safely for almost 20 years around the world in over two million patients, with no adverse events reported.